CMLHope.Com
A Worldwide Support Network For Chronic Myelogenous Leukemia
Posted by rob on October 25, 2007 under Uncategorized | Be the First to Comment
Molecular diagnosis and monitoring in the clinical management of patients with chronic myelogenous leukemia treated with tyrosine kinase inhibitors.
A review of the clinical and economic outcomes of imatinib in Philadelphia chromosome-positive acute lymphoblastic leukemia.
You must be logged in to post a comment.
Add A Comment
You must be logged in to post a comment.